Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study
- PMID: 36551830
- PMCID: PMC9775955
- DOI: 10.3390/biomedicines10123074
Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study
Abstract
Severe acute respiratory syndrome (SARS)-CoV-2 from the family Coronaviridae is the cause of the outbreak of severe pneumonia, known as coronavirus disease 2019 (COVID-19), which was first recognized in 2019. Various potential antiviral drugs have been presented to hinder SARS-CoV-2 or treat COVID-19 disease. Side effects of these drugs are among the main complicated issues for patients. Natural compounds, specifically primary and secondary herbal metabolites, may be considered as alternative options to provide therapeutic activity and reduce cytotoxicity. Phenolic materials such as epigallocatechin gallate (EGCG, polyphenol) and quercetin have shown antibacterial, antifungal, antiviral, anticancer, and anti-inflammatory effects in vitro and in vivo. Therefore, in this study, molecular docking was applied to measure the docking property of epigallocatechin gallate and quercetin towards the transmembrane spike (S) glycoprotein of SARS-CoV-2. Results of the present study showed Vina scores of -9.9 and -8.3 obtained for EGCG and quercetin by CB-Dock. In the case of EGCG, four hydrogen bonds of OG1, OD2, O3, and O13 atoms interacted with the Threonine (THR778) and Aspartic acid (ASP867) amino acids of the spike glycoprotein (6VSB). According to these results, epigallocatechin gallate and quercetin can be considered potent therapeutic compounds for addressing viral diseases.
Keywords: SARS-CoV-2; antiviral activity; natural compounds; severe pneumonia; transmembrane spike glycoprotein.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Aljelehawy Q.H.A., Alshaibah L.H.H., Khafaji Z.K.A.A. Evaluation of virulence factors among Staphylococcus aureus strains isolated from patients with urinary tract infection in Al-Najaf Al-Ashraf teaching hospital. Cell. Mol. Biomed. Rep. 2021;1:78–87. doi: 10.55705/cmbr.2021.144995.1017. - DOI
-
- Ahmadi S., Ahmadi G., Ahmadi H. A review on antifungal and antibacterial activities of some medicinal plants. Micro Nano Bio Asp. 2022;1:10–17.
-
- Alavi M., Rai M. Antisense RNA, the modified CRISPR-Cas9, and metal/metal oxide nanoparticles to inactivate pathogenic bacteria. Cell. Mol. Biomed. Rep. 2021;1:52–59. doi: 10.55705/cmbr.2021.142436.1014. - DOI
-
- Amraei S., Ahmadi S. Recent studies on antimicrobial and anticancer activities of saponins: A mini-review. Nano Micro Bios. 2022;1:22–26.
-
- Muhammad I., Sale P.M., Salisu M.K., Muhammad T.M., Abubakar B., Maidala A.L., Nuwanyada E. Molecular analysis of Bio-makers of Chloroquine resistance in Plasmodium falciparum Isolate from Gombe Local Government Area, Gombe State, Nigeria. Cell. Mol. Biomed. Rep. 2022;2:42–55. doi: 10.55705/cmbr.2022.335753.1033. - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous
